Literature DB >> 17030296

Auditing outcomes and costs of integrated complementary medicine provision--the importance of length of follow up.

Nicola Robinson1, Julie Donaldson, Hilary Watt.   

Abstract

A retrospective audit was carried out on 58 patients with chronic health problems who were referred by 22 general practitioners (GPs) for acupuncture, aromatherapy, homeopathy, massage and osteopathy, or a combination. Costs of GP consultations, prescriptions, secondary care referrals, and diagnostic tests from records of 33 of these patients were compared pre (24 months), during (mean 4.3 months) and post (mean 5.7 months) complementary medicine (CM) treatment. Patient centred outcome data included the Measure Yourself Medical Outcome Profile (MYMOP) and content analysis of patient and practitioner comments. Costs of GP consultations/patient/month were significantly higher during (20.10 pounds, p<0.001) and post (17.53 pounds, p<0.01) CM treatment compared with pre-treatment costs (11.27 pounds). Total prescription costs were not significantly higher during and post-treatment than pre-treatment. Prescription costs for referred conditions were lower during (2.26 pounds) and higher post-treatment (3.75 pounds) compared with costs pre-treatment (3.24 pounds). Pre- and post-treatment MYMOP scores indicated significant improvements in health and well-being. Longer follow up, is required in order to demonstrate significant cost savings related to CM provision. Cost comparisons with conventional medicine should consider quantitative and qualitative data to capture the wider benefits experienced by patients.

Entities:  

Mesh:

Year:  2006        PMID: 17030296     DOI: 10.1016/j.ctcp.2006.07.007

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  10 in total

1.  Integrative medicine - traditional Chinese medicine, a model ?

Authors:  Nicola Robinson
Journal:  Chin J Integr Med       Date:  2011-01-22       Impact factor: 1.978

2.  The use of economic evaluation in CAM: an introductory framework.

Authors:  Emily Ford; Daniela Solomon; Jon Adams; Nicholas Graves
Journal:  BMC Complement Altern Med       Date:  2010-11-11       Impact factor: 3.659

Review 3.  Economic evaluations of homeopathy: a review.

Authors:  Petter Viksveen; Zofia Dymitr; Steven Simoens
Journal:  Eur J Health Econ       Date:  2013-02-10

4.  Economic impact of homeopathic practice in general medicine in France.

Authors:  Aurélie Colas; Karine Danno; Cynthia Tabar; Jenifer Ehreth; Gérard Duru
Journal:  Health Econ Rev       Date:  2015-07-08

5.  Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations.

Authors:  Patricia M Herman; Beth L Poindexter; Claudia M Witt; David M Eisenberg
Journal:  BMJ Open       Date:  2012-09-03       Impact factor: 2.692

6.  Allopathic versus Homeopathic Strategies and the Recurrence of Prescriptions: Results from a Pharmacoeconomic Study in Italy.

Authors:  Andrea Basili; Francesco Lagona; Paolo Roberti di Sarsina; Corallina Basili; Teresa Valeria Paterna
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-21       Impact factor: 2.629

7.  How do we evaluate outcome in an integrative oncology program?

Authors:  S M Sagar
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677

Review 8.  The impact of NHS based primary care complementary therapy services on health outcomes and NHS costs: a review of service audits and evaluations.

Authors:  Lesley Wye; Deborah Sharp; Alison Shaw
Journal:  BMC Complement Altern Med       Date:  2009-03-06       Impact factor: 3.659

9.  Integrative medicine: a tale of two clinics.

Authors:  Heather S Boon; Natasha Kachan
Journal:  BMC Complement Altern Med       Date:  2008-06-18       Impact factor: 3.659

Review 10.  Economic Evaluation of Complementary and Alternative Medicine in Oncology: Is There a Difference Compared to Conventional Medicine?

Authors:  Jutta Huebner; Franz J Prott; Ralph Muecke; Christoph Stoll; Jens Buentzel; Karsten Muenstedt; Oliver Micke
Journal:  Med Princ Pract       Date:  2016-09-07       Impact factor: 1.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.